Neurogenetics

To develop successful therapies for Parkinson disease, we must identify and understand the molecular events occurring. Our objective is to provide symptomatic relief by stopping disease progression. With the help of families in which two or more individuals have been diagnosed with Parkinson disease, and with the help of communities and populations in which the disease is most prevalent, this group is working to identify genetic risk factors. Over the past decade, we have discovered many of the genes involved in Parkinson disease and are developing new models and new treatments.